OLD National Bancorp IN Invests $164,000 in Core Scientific, Inc. (NASDAQ:CORZ)

OLD National Bancorp IN bought a new position in Core Scientific, Inc. (NASDAQ:CORZ) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 13,857 shares of the company’s stock, valued at approximately $164,000.

Several other institutional investors have also made changes to their positions in the stock. Banque Cantonale Vaudoise acquired a new stake in Core Scientific in the second quarter valued at approximately $28,000. Aspect Partners LLC bought a new position in shares of Core Scientific in the first quarter valued at approximately $29,000. Sunbelt Securities Inc. bought a new position in Core Scientific during the second quarter worth $33,000. Hexagon Capital Partners LLC bought a new position in Core Scientific during the first quarter worth $34,000. Finally, Rise Advisors LLC bought a new position in Core Scientific during the second quarter worth $65,000.

Core Scientific Price Performance

NASDAQ CORZ opened at $13.52 on Thursday. Core Scientific, Inc. has a 12 month low of $2.61 and a 12 month high of $14.01. The stock has a 50 day moving average of $11.42 and a 200-day moving average of $8.51.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings results on Wednesday, August 7th. The company reported ($4.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($4.47). The business had revenue of $141.10 million during the quarter, compared to analyst estimates of $128.58 million. Core Scientific’s quarterly revenue was up 11.2% on a year-over-year basis. As a group, equities analysts expect that Core Scientific, Inc. will post 0.01 earnings per share for the current year.

Insiders Place Their Bets

In other Core Scientific news, insider Todd M. Duchene sold 11,582 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $9.41, for a total transaction of $108,986.62. Following the transaction, the insider now owns 1,686,474 shares in the company, valued at $15,869,720.34. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Core Scientific news, insider Todd M. Duchene sold 11,582 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $9.41, for a total transaction of $108,986.62. Following the transaction, the insider now owns 1,686,474 shares in the company, valued at $15,869,720.34. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Denise Marie Brucia Sterling sold 8,752 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $9.41, for a total value of $82,356.32. Following the transaction, the chief financial officer now owns 122,217 shares in the company, valued at $1,150,061.97. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have bought 12,761 shares of company stock worth $127,080 in the last 90 days. Company insiders own 32.00% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $17.00 target price on shares of Core Scientific in a research report on Tuesday, September 10th. HC Wainwright boosted their target price on shares of Core Scientific from $11.00 to $15.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Cantor Fitzgerald restated an “overweight” rating and issued a $20.00 target price on shares of Core Scientific in a research note on Thursday, October 3rd. Canaccord Genuity Group initiated coverage on shares of Core Scientific in a research note on Monday, September 23rd. They issued a “buy” rating and a $16.00 target price on the stock. Finally, Needham & Company LLC upped their price target on shares of Core Scientific from $16.00 to $17.00 and gave the stock a “buy” rating in a research report on Wednesday. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $16.50.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.